Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Genetic control of the cell division cycle in yeast.
|
Science
|
1974
|
13.83
|
2
|
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
|
Gastroenterology
|
1993
|
5.41
|
3
|
A p53-dependent mouse spindle checkpoint.
|
Science
|
1995
|
4.01
|
4
|
Regulation of mating in the cell cycle of Saccharomyces cerevisiae.
|
J Cell Biol
|
1977
|
3.68
|
5
|
Evolution of neoplastic cell lineages in Barrett oesophagus.
|
Nat Genet
|
1999
|
3.30
|
6
|
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.
|
Proc Natl Acad Sci U S A
|
1996
|
2.53
|
7
|
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.
|
Am J Gastroenterol
|
2001
|
2.21
|
8
|
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
|
Gastroenterology
|
1987
|
2.15
|
9
|
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.
|
Genome Res
|
2000
|
2.13
|
10
|
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.
|
Cancer Res
|
2001
|
2.06
|
11
|
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus.
|
Ann Intern Med
|
2000
|
2.05
|
12
|
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
|
Gastroenterology
|
1992
|
2.03
|
13
|
Hereditary gastrointestinal polyposis syndromes.
|
Am J Surg Pathol
|
1986
|
1.91
|
14
|
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR.
|
Genome Res
|
1999
|
1.90
|
15
|
Progression to cancer in Barrett's esophagus is associated with genomic instability.
|
Lab Invest
|
1989
|
1.83
|
16
|
Comparative genomic analysis of tumors: detection of DNA losses and amplification.
|
Proc Natl Acad Sci U S A
|
1995
|
1.75
|
17
|
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.
|
Cancer Res
|
1997
|
1.67
|
18
|
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.
|
Cancer Res
|
1992
|
1.65
|
19
|
p53-mutant clones and field effects in Barrett's esophagus.
|
Cancer Res
|
1999
|
1.61
|
20
|
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest.
|
Mol Cell Biol
|
1999
|
1.56
|
21
|
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.
|
Proc Natl Acad Sci U S A
|
1992
|
1.56
|
22
|
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
|
Proc Natl Acad Sci U S A
|
1991
|
1.53
|
23
|
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.
|
Cancer Res
|
1994
|
1.52
|
24
|
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas.
|
Cancer Res
|
1994
|
1.49
|
25
|
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms.
|
Oncogene
|
1996
|
1.46
|
26
|
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
|
J Natl Cancer Inst
|
1999
|
1.44
|
27
|
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia.
|
Gastroenterology
|
1994
|
1.43
|
28
|
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.
|
Proc Natl Acad Sci U S A
|
1993
|
1.40
|
29
|
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.
|
Cancer Res
|
1991
|
1.39
|
30
|
Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.
|
Oncogene
|
1996
|
1.32
|
31
|
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus.
|
Am J Gastroenterol
|
2000
|
1.25
|
32
|
Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay.
|
Histopathology
|
1990
|
1.24
|
33
|
Genotypic analysis of multiple loci in somatic cells by whole genome amplification.
|
Nucleic Acids Res
|
1995
|
1.24
|
34
|
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities.
|
Gastroenterology
|
1998
|
1.24
|
35
|
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.
|
Cancer Res
|
1996
|
1.14
|
36
|
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer.
|
Gastroenterology
|
1991
|
1.11
|
37
|
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk.
|
Am J Pathol
|
1988
|
1.10
|
38
|
High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues.
|
Biotechniques
|
2002
|
1.08
|
39
|
The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
|
Cancer
|
1994
|
1.05
|
40
|
Multiple keratoacanthomata. A unique case and review of the current classification.
|
Acta Derm Venereol
|
1978
|
1.04
|
41
|
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
|
Cancer Res
|
1991
|
0.99
|
42
|
Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
|
Lab Invest
|
1989
|
0.99
|
43
|
Impact of composting strategies on the treatment of soils contaminated with organic pollutants.
|
Environ Pollut
|
2001
|
0.99
|
44
|
Barrett's esophagus and adenocarcinoma.
|
Annu Rev Med
|
1987
|
0.99
|
45
|
Endoscopic biopsy technique for acquiring larger mucosal samples.
|
Gastrointest Endosc
|
1991
|
0.97
|
46
|
Barrett's esophagus: a model of human neoplastic progression.
|
Cold Spring Harb Symp Quant Biol
|
1994
|
0.97
|
47
|
Biomarkers in Barrett esophagus.
|
Mayo Clin Proc
|
2001
|
0.97
|
48
|
Persistent clonal areas and clonal expansion in Barrett's esophagus.
|
Cancer Res
|
1992
|
0.97
|
49
|
Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
|
Gastroenterology
|
1989
|
0.97
|
50
|
Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus.
|
Nutr Cancer
|
2000
|
0.94
|
51
|
Application of a luminescence-based biosensor for assessing naphthalene biodegradation in soils from a manufactured gas plant.
|
Environ Pollut
|
2009
|
0.90
|
52
|
p53 and neoplastic progression in Barrett's esophagus.
|
Am J Gastroenterol
|
2001
|
0.89
|
53
|
Study of tinea capitis in Philadelphia using case and control groups.
|
Public Health Rep
|
1968
|
0.87
|
54
|
Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas.
|
Pancreas
|
1995
|
0.86
|
55
|
Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.
|
Dig Dis Sci
|
1989
|
0.86
|
56
|
Actinic granuloma in association with giant cell arteritis: are both caused by sunlight?
|
Pathology
|
1997
|
0.86
|
57
|
Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas.
|
Gastroenterology
|
1991
|
0.85
|
58
|
Barrett's esophagus: the biology of neoplastic progression.
|
Gastroenterol Clin Biol
|
1994
|
0.85
|
59
|
Loss of heterozygosity in childhood de novo acute myelogenous leukemia.
|
Blood
|
2001
|
0.83
|
60
|
Oxytetracycline in the treatment of ocular rosacea: a double-blind trial.
|
Br J Ophthalmol
|
1982
|
0.82
|
61
|
Unfamiliar aspects of familial polyposis coli.
|
Am J Surg
|
1986
|
0.78
|
62
|
Exophiala werneckii causing tinea nigra in Scotland.
|
Br J Dermatol
|
1998
|
0.78
|
63
|
Comparison of selected non-exhaustive extraction techniques to assess PAH availability in dissimilar soils.
|
Chemosphere
|
2005
|
0.75
|
64
|
A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma.
|
IEEE Trans Biomed Eng
|
2001
|
0.75
|
65
|
Potential sources of type I error and possible solutions to avoid a "galloping" alpha rate.
|
Nurs Res
|
1983
|
0.75
|
66
|
Letter: Tetracyclines in gonorrhea therapy.
|
N Engl J Med
|
1976
|
0.75
|
67
|
The influence of a NAPL on the loss and biodegradation of 14C-phenanthrene residues in two dissimilar soils.
|
Chemosphere
|
2007
|
0.75
|
68
|
Re: 'Competence of Nursing Graduates in Technical, Communicative, and Administrative Skills'.
|
Nurs Res
|
1979
|
0.75
|
69
|
New record for Aedes thelcter in Arizona.
|
J Am Mosq Control Assoc
|
1990
|
0.75
|